Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABSI Absci Corporation.

Pre-Mkt 03-24 09:07:21 EDT

2.93

-0.03

-1.01%

盘前2.90

-0.03-1.02%

09:06 EDT

High3.04	Low2.86	Vol3.81M
Open3.00	D1 Closing2.96	Amplitude6.25%
Mkt Cap440.59M	Tradable Cap372.11M	Total Shares150.37M
T/O11.19M	T/O Rate3.00%	Tradable Shares127.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABSI","market":"US","secType":"STK","nameCN":"Absci Corporation.","latestPrice":2.93,"timestamp":1774296000000,"preClose":2.96,"halted":0,"volume":3812279,"hourTrading":{"tag":"盘前","latestPrice":2.9,"preClose":2.93,"latestTime":"09:06 EDT","volume":7829,"amount":23246.6011602,"timestamp":1774357564776,"change":-0.03,"changeRate":-0.010239,"amplitude":0.03413},"delay":0,"changeRate":-0.01013513513513507,"floatShares":127000000,"shares":150371531,"eps":-0.896554,"marketStatus":"Pre-Mkt","change":-0.03,"latestTime":"03-24 09:07:21 EDT","open":3,"high":3.04,"low":2.855,"amount":11194708.486328801,"amplitude":0.0625,"askPrice":2.92,"askSize":90,"bidPrice":2.89,"bidSize":53,"shortable":3,"etf":0,"ttmEps":-0.896554,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"listingDate":1626926400000,"exchange":"NASDAQ","adjPreClose":2.93,"preHourTrading":{"tag":"盘前","latestPrice":2.9,"preClose":2.93,"latestTime":"09:06 EDT","volume":7829,"amount":23246.6011602,"timestamp":1774357564776,"change":-0.03,"changeRate":-0.010239,"amplitude":0.03413},"postHourTrading":{"tag":"盘后","latestPrice":2.9593,"preClose":2.93,"latestTime":"19:45 EDT","volume":42519,"amount":124684.2138,"timestamp":1774309508294,"change":0.0293,"changeRate":0.01,"amplitude":0.033925},"volumeRatio":0.600211905112641,"impliedVol":1.4036,"impliedVolPercentile":0.796},"requestUrl":"/m/hq/s/ABSI","defaultTab":"news","newsList":[{"id":"2621640220","title":"Absci Corp - Launches Endometriosis Advisory Board for Abs-201 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2621640220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621640220?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:23","pubTimestamp":1774354990,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C09Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABSI","BK4121","BK4139","BK4539"],"gpt_icon":0},{"id":"2621064346","title":"Absci launches ABS-201 endometriosis advisory board","url":"https://stock-news.laohu8.com/highlight/detail?id=2621064346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621064346?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:01","pubTimestamp":1774353671,"startTime":"0","endTime":"0","summary":"Absci announced the ABS-201 program for endometriosis and launched an external advisory board to support clinical strategy and study design.The program targets a large unmet-need market, with endometriosis affecting an estimated 190 million people worldwide.ABS-201 is positioned as a non-hormonal approach, which could differentiate it from current treatments that rely on hormonal suppression.The company said it anticipates initiating a Phase 2 study in Q4 2026, with an interim data readout expected in the second half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL7hv80h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","LU2210150020.SGD","SG9999014005.SGD","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4539","LU0314104364.USD","LU2210149790.SGD","BK4121","IE00BKPKM429.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","BK4112","BK4585","BK4139"],"gpt_icon":0},{"id":"2621084103","title":"Top News Today/Canada: Bank of Canada to Lose Two Members of Rate-Setting Governing Council","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084103","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084103?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:30","pubTimestamp":1774297800,"startTime":"0","endTime":"0","summary":"The Bank of Canada said that two members of its rate-setting governing council are departing, and it intends to fill the vacancies internally.The central bank said that Deputy Governor Rhys Mendes would leave on April 10, to relocate to Toronto with his family. He was responsible for the central bank's analysis of international economic developments.Deputy Governor Sharon Kozicki intends to retire on July 15, following a two-decade career at Canada's central bank. She was responsible for overseeing analysis of domestic economic developments.BOC Speech Takes on Heightened Importance Amid Rapid Turn in Rate Expectations. LaGuardia Airport Reopens Hours After Deadly Runway Collision. New York City's LaGuardia Airport was closed Monday after a passenger jet collided with an emergency vehicle on the runway, killing two pilots and injuring dozens of other people.The two pilots of the Air Canada Express plane were killed in the crash shortly before midnight Sunday, and a further 41 people, in","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHV","PVL","BK4082","INTZ","AIRJ","LU1923621640.USD","LU2065170008.USD","ATOS","BK4007","BK4023","BK4539","BK4198","BK4139","COLFF","KBH","ABSI","BK4161","IE00B19Z4B17.USD","LU2125910336.SGD","BK4104","BZAI","MXCT","EPSN","LU2125910179.SGD","IE00B7SZL793.SGD","NKTX","CNM","LU2065169927.USD","KZR","BK4187","BK4141","CNXC","TIL","PAYS","BK4135","SFES","IE0009354923.USD","LU2089985449.USD","BK4505","ECTM","LU2065171402.SGD","BRZE","AIR","SMTI","LENZ","GUTS","SFD","BK4572","BK4213","BK4588"],"gpt_icon":0},{"id":"2621583774","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2621583774","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621583774?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:00","pubTimestamp":1774260000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBS","MXCT","CCL","FEMY","BRZE","ABOS","EQ","KALV","ACHV","HYPD","FBRX","ABVX","CNTB","BTGO","FUL","AUTL","BZAI","CHWY","ABSI","IMDX","KBH","IMNN","EDAP","EVTL","CMC","CNM","CNTA","CNXC","HSAI","BCAX","IKT","CELC","CGNT","BAK","CNTX","AGX","DERM","GUTS","DPRO","CTAS","BYND","FENC","DEFT","DOO","EPAC","GOVX","HUMA","AIR","AVTX","JEF"],"gpt_icon":0},{"id":"2621754357","title":"Absci Corp  expected to post a loss of 19 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754357","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754357?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:43","pubTimestamp":1774039387,"startTime":"0","endTime":"0","summary":"Absci Corp  expected to post a loss of19cents a share - Earnings Preview Absci Corp ABSI.OQ ABSI.O is expected to  show a rise in quarterly revenue when it reports  results on March 24 for the period ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4082C0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4121","BK4539","ABSI"],"gpt_icon":0},{"id":"2620782840","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2620782840","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620782840?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:00","pubTimestamp":1774000800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNN","BTGO","BYND","EVTL","ABVX","KALV","ACHV","ALMS","AVTX","JBS","AGX","CNXC","FEMY","GOVX","MXCT","KBH","AIR","CNTB","EDAP","BRZE","CNM","FENC","CNTX","BZAI","CUK","CNTA","CELC","FBRX","CGNT","GUTS","KOD","HSAI","CTAS","FUFU","FUL","DOO","HUMA","ABSI","BAK","EPAC","BCAX","EQ","CMC","HYPD","DERM","KRMN","CHWY","JEF","IKT"],"gpt_icon":1},{"id":"2620423757","title":"Absci Price Target Maintained With a $7.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2620423757","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620423757?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:59","pubTimestamp":1773831540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2026 06:59 ET (10:59 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABSI","BK4121"],"gpt_icon":0},{"id":"2620311922","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2620311922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620311922?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:00","pubTimestamp":1773828000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Accenture Plc A                                  2Q      2.85   6:39 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX","ELDN","DRI","FIVE","CAL","BIOA","CLLS","CDNL","AVAH","FDX","CRIS","CURV","MXCT","CUK","CELC","CCL","GEMI","CING","GUTS","HNRG","AVR","BZAI","GIS","EQPT","ECOR","CNXC","DLO","BRZE","EVTL","ARX","DRIO","DERM","ALVO","FLY","GANX","ACN","BRAG","GRWG","ARCO","ABSI","BZ","BABA","CNM","FUFU","BGSI","FBRX","ETON","AEBI","AIR"],"gpt_icon":1},{"id":"2617658262","title":"BRIEF-Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658262","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658262?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:44","pubTimestamp":1772833467,"startTime":"0","endTime":"0","summary":"BRIEF-Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)March 6 (Reuters) - Absci Corp ABSI.O:ABSCI ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNXsX277Further company coverage: ABSI.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nTUA3G8MHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4121","ABSI","BK4139"],"gpt_icon":0},{"id":"2617658696","title":"Absci names Ransi Somaratne chief medical officer as Andreas Busch set to retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658696","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658696?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:21","pubTimestamp":1772832073,"startTime":"0","endTime":"0","summary":"Absci Corporation appointed Ransi Somaratne, M.D., as Chief Medical Officer to lead clinical development for its AI-designed therapeutics pipeline. Somaratne previously served as Senior Vice President of Clinical Development at Vertex Pharmaceuticals and held leadership roles at BioMarin Pharmaceutical and Amgen. Chief Innovation Officer Andreas Busch will retire from his executive role on March 31, 2026. Busch will continue with the company as co-chair of Absci’s Scientific Advisory Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Absci Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL6SyRmp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","VRTX","LU0109394709.USD","LU0868494617.USD","ABSI","IE00B894F039.SGD","LU2112291526.USD","IE00B19Z3581.USD","LU0256863811.USD","BK4588","LU1035775433.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU2324357040.USD","LU1069344957.HKD","LU0234570918.USD","SGXZ57979304.SGD","LU2417539215.USD","LU0432979614.USD","LU1430594728.SGD","SG9999001176.SGD","IE00B19Z9P08.USD","LU0122379950.USD","BK4566","LU1983299246.USD","LU2236285917.USD","LU1571399168.USD","AMGN","LU1023059063.AUD","LU2362541513.USD","BK4599","BK4534","LU1057294990.SGD","LU0061475181.USD","LU0889565916.HKD","LU2468319806.SGD","LU1674673428.USD","LU0058720904.USD","BK4581","LU0417517546.SGD","IE00B4R5TH58.HKD","BK4539","BMRN","LU0079474960.USD","IE00BZ9MQY76.HKD","LU0823416689.USD","IE0002270589.USD","SG9999001440.SGD","BK4121"],"gpt_icon":0},{"id":"2617630721","title":"Absci Grants 650,000-Share Inducement Stock Option to New CMO Dr. Ransi Somaratne","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630721","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630721?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:05","pubTimestamp":1772831118,"startTime":"0","endTime":"0","summary":"Absci Corporation granted Chief Medical Officer Dr. Ransi Somaratne a non-statutory stock option to purchase 650,000 shares. The option has an exercise price of $2.57 per share, a 10-year term, and vests over four years, with 25% vesting after one year and the remaining 75% vesting in 36 roughly equal monthly installments thereafter, subject to continued service.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL7STrFs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","LU2095319765.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4139","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4121","LU2210149790.SGD","SG9999014039.USD","ABSI","BK4112","LU2210150020.SGD","BK4539","BK4585","SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD","NDAQ"],"gpt_icon":0},{"id":"2616773673","title":"Absci Director Menelas N Pangalos Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616773673","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616773673?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:09","pubTimestamp":1772575740,"startTime":"0","endTime":"0","summary":"Menelas N Pangalos, a director, reported an acquisition of common shares of Absci Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Absci Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL2NnqBP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Absci Director Menelas N Pangalos Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4139","BK4121","BK4539"],"gpt_icon":0},{"id":"2616328898","title":"BRIEF-Absci Strengthens Clinical Leadership With Appointment Of Ransi Somaratne, M.D., FACC, Mba As Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2616328898","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616328898?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:04","pubTimestamp":1772543090,"startTime":"0","endTime":"0","summary":"BRIEF-Absci Strengthens Clinical Leadership With Appointment Of Ransi Somaratne, M.D., FACC, Mba As Chief Medical OfficerMarch 3 (Reuters) - Absci Corp ABSI.O:ABSCI STRENGTHENS CLINICAL LEADERSHIP WIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA31QFGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABSI","BK4539","BK4139"],"gpt_icon":0},{"id":"2616404343","title":"Absci Strengthens Clinical Leadership With Appointment of Ransi Somaratne, M.d., Facc, MBA as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2616404343","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616404343?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:00","pubTimestamp":1772542808,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA31QFGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4121","BK4539","ABSI"],"gpt_icon":0},{"id":"2616340760","title":"Press Release: Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2616340760","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616340760?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:00","pubTimestamp":1772542800,"startTime":"0","endTime":"0","summary":"Former Vertex executive to spearhead the clinical development of Absci's expanding AI-designed therapeutics pipeline. Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue to co-chair Absci's Scientific Advisory Board. VANCOUVER, Wash. and NEW YORK, March 03, 2026  -- Absci Corporation , a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer. Dr. Somaratne will spearhead the clinical development strategy and execution for Absci's expanding pipeline of AI-designed therapeutics.Dr. Somaratne is a physician-scientist and seasoned biopharmaceutical executive who joins Absci from Vertex Pharmaceuticals, where he served as Senior Vice President of Clinical Development. He previously held various scientific leadership roles at BioMarin Pharmaceutical and Amgen.Alongside Dr. Somaratne's appointment, Absci announced the ret","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","AIYY","03160","BK4196","BK4232","BK4139","BK4555","MD","BK4551","BK4022","BK4121","BK4023","BK4604","R","BK4539","BK4585","BK4528","ABSI","BK4587","BK4099","TM","BK4588"],"gpt_icon":1},{"id":"2613711400","title":"Absci Corporation Updates Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2613711400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613711400?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:02","pubTimestamp":1771938163,"startTime":"0","endTime":"0","summary":"Absci Corporation Updates Financial Calendar               Absci Corporation will report business updates and its fourth quarter and full year 2025 financial and operating results after market close o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL2yXjKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","LU2095319765.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4139","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4121","LU2210149790.SGD","SG9999014039.USD","ABSI","BK4112","LU2210150020.SGD","BK4539","BK4585","SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD","NDAQ"],"gpt_icon":0},{"id":"2610666389","title":"11 Stocks That Have Cratered and Look Like Buys -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2610666389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610666389?lang=en_us&edition=fundamental","pubTime":"2026-02-10 03:22","pubTimestamp":1770664920,"startTime":"0","endTime":"0","summary":"Sometimes, an opportunity to buy something is hiding in plain sight. That is a distinct possibility today, considering the tons of stocks that have crashed recently.Enormous drops in stocks have historically provided some of the best buying opportunities. When a concern emerges, prices fall to levels that fully reflect the worry, whether the risk that caused the selloff materializes or not. That sets the shares up to benefit from any improvement in sentiment.Elsewhere, companies that provide private loans and equity financing, via private investment funds, have seen their stocks tank. Even shares of the investment bank Jefferies, which owns a stake in a hedge fund that had exposure to private credit, are down 14% from a multimonth high hit in September. To make the list, short interest had to be in the 65th percentile of the historic range for each company, or higher, meaning that the st","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044949.HKD","LU0127658192.USD","LU0149725797.USD","IE0004445015.USD","LU0211326755.USD","LU1670628061.USD","BK4528","LU1037948541.HKD","LU1814569148.SGD","IE00B4JS1V06.HKD","LU0081259029.USD","LU1267930227.SGD","LU0965509101.SGD","IE00BJJMRX11.SGD","LU1934455277.USD","BK4538","LU2023250843.SGD","LU2210149790.SGD","LU2491050071.SGD","SGXZ51526630.SGD","IE00BYQQ9H92.USD","SG9999001176.SGD","IE00B775H168.HKD","LU1066053197.SGD","LU0238689110.USD","LU1815333072.USD","LU0912757837.SGD","LU2111349929.HKD","LU1064131342.USD","IE00BWXC8680.SGD","LU2237438978.USD","LU0158827781.USD","LU1267930490.SGD","LU1267930573.SGD","BK4097","IE0009355771.USD","LU2317271919.USD","LU1951200564.SGD","IE0009356076.USD","LU0823416689.USD","SG9999002224.SGD","LU0354030511.USD","LU0053666078.USD","LU2125909916.SGD","LU0006306889.USD","LU2756315318.SGD","LU0061474960.USD","LU0511384066.AUD","LU2458330243.SGD","LU2106854487.HKD","LU1854103824.USD","LU0058720904.USD","LU0545039389.USD","LU0980610538.SGD","LU2125154935.USD","LU2468319806.SGD","IE00B19Z9Z06.USD","LU1261432733.SGD","LU0310800965.SGD","BK4581","LU1923623000.USD","LU0820561818.USD","LU1623119135.USD","LU0107464264.USD","LU1116320901.HKD","LU1983299246.USD","LU0976567544.SGD","LU0265550946.USD","LU0965509010.AUD","LU2089283258.USD","LU0130517989.USD","LU0256863811.USD","ADBE","LU2089284900.SGD","LU1791710582.SGD","BK4554","BK4567","LU0742534661.SGD","LU1074936037.SGD","UNH","LU0109392836.USD","LU0203347892.USD","LU2552382058.USD","LU0943347566.SGD","LU1291159041.SGD","LU1674673691.USD","LU0861579265.USD","LU1267930730.SGD","LU0708994859.HKD","LU0114720955.EUR","SGXZ81514606.USD","LU2125909593.SGD","LU1323610961.USD","LU1989771016.USD","BK4566","IE0005OL40V9.USD","BK4585","LU0353189763.USD","LU0472753341.HKD","LU2362540622.SGD","LU1316542783.SGD","LU0106261372.USD","LU1923622291.USD","LU1823568750.SGD","LU1035773651.USD","LU1691799644.USD","BK4607","LU0345774631.USD","LU0094547139.USD","IE00B1XK9C88.USD","LU0345770993.USD","LU2362541273.HKD","LU0342679015.USD","LU1974910355.USD","LU0353189680.USD","LU0211327993.USD","IE00BFXG1179.USD","LU0823434740.USD","LU2023251221.USD","IE00B894F039.SGD","LU1791710400.SGD","LU2095319765.USD","IE00B2B36J28.USD","LU1366333091.USD","LU0882574055.USD","LU0792757196.USD","LU1934455863.HKD","IE0002141913.USD","LU0823434583.USD","LU2361044865.SGD","LU0048584097.USD","LU0868494617.USD","LU0889566641.SGD","SG9999018865.SGD","IE00BFTCPJ56.SGD","LU0057025933.USD","IE00BZ9MQY76.HKD","LU0942090050.USD","IE00BKVL7J92.USD","LU0251131958.USD","LU0310799852.SGD","LU2125154778.USD","IE00B19Z9505.USD","IE00BJTD4V19.USD","LU1854104046.USD","LU2133065610.SGD","IE00BFSS7M15.SGD","LU0787776722.HKD","LU2362541513.USD","LU2125909247.SGD","LU0642271901.SGD","ABCL","LU2433249047.HKD","LU0310800379.SGD","LU1057294990.SGD","LU0203345920.USD","LU0965508806.USD","LU0456855351.SGD","LU2357305700.SGD","IE00B5TLWC47.USD","IE00B1BXHZ80.USD","LU1061106388.HKD","LU2112291526.USD","LU2347655156.SGD","LU0889565833.HKD","LU0683600562.USD","LU0345774391.USD","LU0348723411.USD","LU2286300806.USD","LU2236285917.USD","LU1267930813.SGD","SGXZ57979304.SGD","LU2552382215.SGD","LU0187121727.USD","LU0477156953.USD","BK4533","LU2247934214.USD","LU0077335932.USD","LU1989764664.SGD","LU0128525929.USD","LU1989772923.USD","LU1496350502.SGD","LU1712237335.SGD","LU0957791311.USD","LU0265550359.USD","UNHG","LU1720051017.SGD","LU2063271972.USD","IE00BJTD4N35.SGD","IE00BZ1G4Q59.USD","LU0820562030.AUD","SG9999014898.SGD","LU2279689827.SGD","LU1917777945.USD","LU0130102774.USD","LU1506573853.SGD","LU0795875169.SGD","IE00BQXX3C00.GBP","LU2244417387.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU1551013342.USD","LU0029864427.USD","IE00BFSS8Q28.SGD","LU0158827948.USD","LU0082616367.USD","LU0267386448.USD","LU1989772840.SGD","LU1201861249.SGD","LU0234570918.USD","LU0738911758.USD","LU2125909759.SGD","IE0004445239.USD","IE00B19Z8W00.USD","LU1670627923.USD","SG9999018857.SGD","LU0965509283.SGD","BK4598","LU0211328371.USD","SG9999017495.SGD","LU0109391861.USD","ABSI","IE00B7KXQ091.USD","SAIL","SDGR","BK4548","LU1066051811.HKD","RXRX","IE00BQXX3D17.EUR","LU1066051498.USD","LU2360032135.SGD","LU0079474960.USD","LU1235294995.USD","IE00BJJMRY28.SGD","LU0251132253.USD","LU0354030438.USD","LU2087625088.SGD","LU2381873111.SGD","BK4505","LU0648001328.SGD","LU0868494708.USD","LU0289739343.SGD","LU0672654240.SGD","LU1119994496.HKD","IE00BMPRXR70.SGD","BK4613","LU0432979614.USD","LU0289739699.SGD","LU0097036916.USD","SG9999001176.USD","NOW","UNHW","LU1551013425.SGD","SG9999001424.SGD","IE00BN29S564.USD","LU0266013472.USD","LU1989764748.USD","LU2361045086.USD","LU0048573561.USD","LU0417517546.SGD","IE00BQXX3F31.USD","LU0345770308.USD","LU2265009873.SGD","IE00BFXG0V08.USD","SGXZ99366536.SGD","BK4579","LU0949170772.SGD","LU1633808545.USD","CRM","LU1496350171.SGD","LU1084165304.USD","LU1066051225.USD","LU2264538146.SGD","BK4550","IE00B7SZLL34.SGD","LU0795875086.SGD","LU1069347547.HKD","LU1803068979.SGD","LU1804176565.USD","LU0069063385.USD","BK4532","SG9999014880.SGD","LU2756315664.SGD","BK4527","SG9999014914.USD","LU0198837287.USD","BK4608","LU0553294199.USD","LU1674673428.USD","LU1914381329.SGD","LU0234572021.USD","LU1732800096.USD","LU0661504455.SGD","LU0320765059.SGD","LU2543165471.USD","LU1778281490.HKD","OWL","IE00B19Z9P08.USD","BK4592","LU0528227936.USD","LU1720051108.HKD","LU1951198990.SGD","WDAY","LU1037948897.HKD","LU0128525689.USD","LU0052756011.USD","SGXZ31699556.SGD","LU0557290698.USD","SG9999014906.USD","LU2023250504.SGD","LU0124676726.USD","IE000M9KFDE8.USD","LU1934455194.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU1003077747.HKD","LU0251142724.SGD","LU1548497426.USD","BK4543","LU1153585028.USD","LU0316494557.USD","LU1718418525.SGD","SG9999013999.USD","BK4588","IE00BSNM7G36.USD","BK4534","IE00BJJMRZ35.SGD","LU0211326839.USD","LU0820561909.HKD","LU2028103732.USD","BK4535","IE00BKPKM429.USD","LU0314104364.USD","IE00BMPRXN33.USD","LU0170899867.USD","LU1988902786.USD","LU0496365809.HKD","LU2210150020.SGD","LU1023059063.AUD","LU2458330169.SGD","LU0157215616.USD","LU2324357040.USD","LU2211815571.USD","LU0289961442.SGD","LU0689626769.HKD","LU2461242641.AUD","BK4154","LU2491049909.HKD","IE00B19Z8X17.USD","IE00B19Z3581.USD","LU2552382132.HKD","IE00B4R5TH58.HKD","BK4503","SG9999000418.SGD","SG9999002232.USD","LU1923622614.USD","LU1732799900.SGD","LU0011850046.USD","LU1046421795.USD","LU0122379950.USD","BK4023","LU2242649171.HKD","LU2271345857.HKD","LU0689472784.USD","LU0708995401.HKD","BK4561","LU0719512351.SGD","LU2491050154.USD","LU1116320737.USD"],"gpt_icon":0},{"id":"2609591192","title":"Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591192","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609591192?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:40","pubTimestamp":1770374408,"startTime":"0","endTime":"0","summary":"Insiders who bought US$582.6k worth of Absci Corporation's ( NASDAQ:ABSI ) stock at an average buy price of US$2.98...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/insiders-who-purchased-us5826k-of-absci-stock-may-not-have-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/insiders-who-purchased-us5826k-of-absci-stock-may-not-have-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABSI","BK4539","BK4139","BK4121"],"gpt_icon":0},{"id":"2606203784","title":"The Genesis Mission Has a 270-Day Timeline – And You’re Already Late","url":"https://stock-news.laohu8.com/highlight/detail?id=2606203784","media":"InvestorPlace","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606203784?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:56","pubTimestamp":1769518560,"startTime":"0","endTime":"0","summary":"The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"investorplace_stock_picks","url":"https://investorplace.com/hypergrowthinvesting/2026/01/miss-these-genesis-mission-stocks-and-youll-regret-it-for-a-decade/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://investorplace.com/hypergrowthinvesting/2026/01/miss-these-genesis-mission-stocks-and-youll-regret-it-for-a-decade/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["TMQ","NVDW","SNVD.UK","TWST","3NVD.UK","NVDQ","TMO","NVD","IONQ","CEG","MULL","2NVD.UK","NVDS","TER","NVDX","ABSI","DIPS","DNA","NVD3.UK","MUD","NVII","HON","NVDY","NNE","SLI","BWXT","SDGR","NVDU","SYM","ROK","WOLF","NVDD","NVDG","AI","NVD2.UK","SKYT","INTC","OKLO","LEU","PPTA","RXRX"],"gpt_icon":1},{"id":"2603623062","title":"Absci Corporation showcases AI-driven antibody discovery and new clinical-stage drug programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623062","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603623062?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:22","pubTimestamp":1768436557,"startTime":"0","endTime":"0","summary":"Absci Corporation presented new developments at the 44th Annual J.P. Morgan Healthcare Conference, highlighting progress in generative AI-driven drug discovery. The company showcased its industrialized platform that combines AI and wet-lab capabilities to accelerate and reduce the cost of drug discovery, moving from initial code to clinical-stage programs in as little as 24 months. The presentation detailed three clinical-stage programs, including ABS-201 for androgenetic alopecia, ABS-201 for endometriosis, and ABS-101 for inflammatory bowel disease . ABS-201, targeting PRLR inhibition, was noted as a potential new category of therapy for hair regrowth, aiming to address significant unmet needs in androgenetic alopecia with an innovative approach distinct from current treatments. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL2mtfp2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4539","BK4139","BK4121"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.absci.com","stockEarnings":[{"period":"1week","weight":0.172},{"period":"1month","weight":0.1057},{"period":"3month","weight":-0.1676},{"period":"6month","weight":0.1767},{"period":"1year","weight":-0.0266},{"period":"ytd","weight":-0.1605}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106318},{"month":2,"riseRate":0.6,"avgChangeRate":0.064917},{"month":3,"riseRate":0.4,"avgChangeRate":-0.090556},{"month":4,"riseRate":0.25,"avgChangeRate":-0.121758},{"month":5,"riseRate":0.25,"avgChangeRate":-0.047908},{"month":6,"riseRate":0,"avgChangeRate":-0.147252},{"month":7,"riseRate":0.75,"avgChangeRate":0.242017},{"month":8,"riseRate":0.2,"avgChangeRate":-0.131623},{"month":9,"riseRate":0.2,"avgChangeRate":-0.114873},{"month":10,"riseRate":0.8,"avgChangeRate":0.133791},{"month":11,"riseRate":0.2,"avgChangeRate":-0.134033},{"month":12,"riseRate":0.4,"avgChangeRate":0.218437}],"exchange":"NASDAQ","name":"Absci Corporation.","nameEN":"Absci Corporation."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Absci Corporation.,ABSI,Absci Corporation.股票,Absci Corporation.股票老虎,Absci Corporation.股票老虎国际,Absci Corporation.行情,Absci Corporation.股票行情,Absci Corporation.股价,Absci Corporation.股市,Absci Corporation.股票价格,Absci Corporation.股票交易,Absci Corporation.股票购买,Absci Corporation.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}